 | • レポートコード：MRC2303G026 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の市場調査書によると、世界のバイオ分析試験サービス市場規模が、2020年には2573.86ドルに及び、予測期間中、CAGR 11.59.％で増加すると推測されています。本書では、バイオ分析試験サービスの世界市場について広く調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、分子種類別（小分子、大分子）分析、検査種類別（生物学的利用能・生物学的同等性試験、薬物動態試験、薬力学試験、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などの項目について記載しています。並びに、本書に記載されている企業情報には、Pharmaceutical Product Development LLC、ICON PLC、Laboratory Corporation of America Holdings、Charles River Laboratories International Inc.などが含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のバイオ分析試験サービス市場規模：分子種類別 - 小分子バイオ分析試験サービスの市場規模 - 大分子バイオ分析試験サービスの市場規模 ・世界のバイオ分析試験サービス市場規模：検査種類別 - 生物学的利用能・生物学的同等性試験の市場規模 - 薬物動態試験の市場規模 - 薬力学試験の市場規模 - その他バイオ分析試験サービスの市場規模 ・世界のバイオ分析試験サービス市場規模：地域別 - 北米のバイオ分析試験サービス市場規模 アメリカのバイオ分析試験サービス市場規模 カナダのバイオ分析試験サービス市場規模 メキシコのバイオ分析試験サービス市場規模 … - ヨーロッパのバイオ分析試験サービス市場規模 ドイツのバイオ分析試験サービス市場規模 イギリスのバイオ分析試験サービス市場規模 フランスのバイオ分析試験サービス市場規模 … - アジア太平洋のバイオ分析試験サービス市場規模 中国のバイオ分析試験サービス市場規模 日本のバイオ分析試験サービス市場規模 インドのバイオ分析試験サービス市場規模 … - 南米/中東のバイオ分析試験サービス市場規模 ブラジルのバイオ分析試験サービス市場規模 アルゼンチンのバイオ分析試験サービス市場規模 サウジアラビアのバイオ分析試験サービス市場規模 … ・競争状況 ・市場機会・将来動向 |
The bioanalytical testing services market was estimated to be USD 2,573.86 in 2020 and is projected to record a CAGR of 11.59%.
Bioanalytical technologies have played a critical role in mitigating the COVID-19 pandemic and will continue to be foundational in the prevention of the subsequent waves of this pandemic, along with future infectious disease outbreaks. Companies, such as SGS, offer a full range of bioanalytical services for both small molecules and biologics, including mass spectrometry, immunoassays, and cell-based assays. In November 2020, SGS, the world’s leading inspection, verification, testing, and certification company, invested in its Biosafety Center of Excellence in Glasgow, boosting its capacity to support scientists and manufacturers in the development of effective vaccines, cell and gene therapies, and other biological medicines.
The major factor contributing to the growth of the market studied is the increased necessity for specific types of tests in R&D activities and the increasing trend of outsourcing laboratory testing services. Due to the increasing trend of outsourcing laboratory testing services, companies are expanding their market share by offering various types of services and solutions. Additionally, major players are focusing on different strategies, such as mergers, acquisitions, and other developments. For instance, in August 2021, Eurofins Scientific signed an agreement with Noritsu Koki Co. Ltd to acquire GeneTech Inc., a leading Japanese player in genetic analysis, to expand Eurofins’ testing portfolio in Japan. The bioanalytical testing service plays an important role; hence, the market is anticipated to grow significantly.
The rise in demand for bioanalytical testing services can also be due to the growing prevalence of infectious diseases, HIV, etc. Additionally, rising government initiatives to control the outbreaks of infectious diseases such as COVID-19 is expected to provide more opportunities, which is expected to contribute to the growth of the market studied.
Bioanalytical Testing Services Market Trends
Small Molecule Sub-segment Expected to Show Better Growth in the Bioanalytical Testing Services Market
The small molecule testing services sub-segment is anticipated to witness growth due to its pivotal role in developing generic versions of branded drugs. Bioanalytical testing plays a significant role in proving the efficiency to simulate generic drug release profiles with that of branded drugs, resulting in the growth of the segment.
On the other hand, the large molecule segment is expected to witness lucrative growth during the forecast period. Bioanalytical testing of large molecules is one of the most challenging tasks for the biopharmaceutical sector. Hence, various techniques are used, such as Maldi-TOF-MS, Ligand Binding Assays, size exclusion affinity chromatography, etc. Bioanalytical testing of large molecules is generally conducted in well-established R&D labs by the biopharmaceutical sector, followed by other Phase II studies, while long-term toxicity studies are mostly outsourced. Hence, outsourcing bioanalytical testing of these molecules is likely to be the prevailing trend over the forecast period.
Owing to the COVID-19 pandemic, many biotech and pharmaceutical firms have been focusing on effective and rapid technologies for the fast diagnosis of COVID-19 and to develop vaccines/therapeutics that can help mitigate the spread by ensuring the appropriateness of care across all healthcare settings and achieving high-quality outcomes, which are further driving demand for the bioanalytical testing services globally. For instance, in July 2020, CIRION BioPharma Research Inc., a US-based GLP-certified contract research laboratory, announced that the company is expanding its bioanalytical services by increasing its existing laboratory facilities to support drug and vaccine developments related to COVID-19. Thus, the small molecule sub-segment is expected to contribute significantly over the forecast period due to the abovementioned factors.
North America Dominates the Market and its Dominance Expected to Continue in the Forecast Period
North America is expected to dominate the bioanalytical testing services market, and this trend is expected to continue over the forecast period. This can be majorly attributed to the growing demand for bioanalytical services with a high volume of ongoing research activities and clinical trials, which is expected to fuel the market growth in the region.
In North America, the US holds the largest market share due to the increased patient pool of various chronic diseases and increased adoption of peptides and other large molecule therapeutics as an alternative to small molecules that have more side effects. According to the Centers for Disease Control and Prevention, around USD 3.5 trillion is spent on chronic diseases in the US. Therefore, companies have been taking initiatives to meet the high demand, which is expected to fuel the market studied.
Moreover, according to the International Diabetes Federation, in 2020, about 48 million adults in North America were living with diabetes, and the trend is expected to continue, resulting in higher demand for bioanalysis of novel therapeutics to stop the growing diabetes patient pool. Thus, the rising demand for bioanalytical services, the large number of ongoing clinical trials, and huge investments by many major pharmaceutical companies are the key factors driving the growth of the market studied in the country.
Bioanalytical Testing Services Market Competitor Analysis
The bioanalytical testing services market is moderately competitive and consists of several major players. Some of the companies are expanding their market position by offering various types of services, launching new methods for assay validation, while others are offering laboratory solutions. Some companies currently dominating the market are SGS SA, ICON PLC, Laboratory Corporation of America Holdings, Syneos Health Inc., Charles River Laboratories Inc., etc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Necessity of Specific Types of Tests in R&D Activities
4.2.2 Increased Trend of Outsourcing Laboratory Testing Services
4.3 Market Restraints
4.3.1 Complex Regulatory Framework for Maintaining Laboratories
4.3.2 Challenges in the Development of Proper Analytical Techniques
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Molecule Type
5.1.1 Small Molecules
5.1.2 Large Molecules
5.2 By Test Type
5.2.1 Bioavailability and Bioequivalence Studies
5.2.2 Pharmacokinetics
5.2.3 Pharmacodynamics
5.2.4 Other Test Types
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Pharmaceutical Product Development LLC
6.1.2 ICON PLC
6.1.3 Laboratory Corporation of America Holdings
6.1.4 Charles River Laboratories International Inc.
6.1.5 Syneos Health
6.1.6 SGS SA
6.1.7 Toxikon Corporation
6.1.8 Intertek Group PLC
6.1.9 Wuxi Apptec Co. Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS